QA: Phaserx INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001429386_2017_Phaserx_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001429386, Phaserx INC

  xvar xval
0 AssetsCurrent 16,177,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 271,000
3 remainder_Assets 0
4 LiabilitiesCurrent 2,024,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,127,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,153,000
9 ResearchAndDevelopmentExpense 6,662,000
10 remainder_Expenses 7,515,000
11 remainder_Revenues 0
12 remainder_NetIncome -1,807,000
13 remainder_ComprehensiveNetIncome 3,000
  yvar yval
0 Assets 16,448,000
1 Liabilities 7,151,000
2 Expenses 18,330,000
3 Revenues 0
4 StockholdersEquity 9,297,000
5 NetIncome -20,137,000
6 ComprehensiveNetIncome -20,135,500
7 BaseVar 21,869,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.0112
9 EconomicCapitalRatio 1.42

Edgar->Model Mapping

Feature Distribution